About Biocon Our Business Research & Development Biocon's Technology Investors Media Careers CSR
Biocon Quarterly Results
  > INVESTORS
  Overview
  Corporate Structure
  Corporate Governance
  Company History
  Annual General Meeting
  Postal Ballot
  Investor FAQs
  Stock Info
  Financial Results
  Subsidiary Financials
  Annual Report
  Disclosure to Stock Exchange
  Nomination form
  Press Releases
  Presentations
  Analyst Coverage
  Investor Contacts
  
  
     
 
Financials

Financial Results

 
 
 
  FY 12-13 Q1 H1 9M FY
  Press Release Press release Q1 FY 2012-13 Press release Q2 FY 2012-13 Press release Q3 FY 2012-13 Press release Q4 FY 2012-13
  Fact Sheet Fact Sheet Q1 FY 2012-13 Fact Sheet Q2 FY 2012-13 Fact Sheet Q3 FY 2012-13 Fact Sheet Q4 FY 2012-13
  Transcript of the Call Transcript of Q1 FY13 Transcript of Q2 FY13 Transcript of Q3 FY13 Transcript of FY2013
  Advertisement
  Investor Presentation Investor Presentation Investor Presentation Investor Presentation Investor Presentation
 
     
  FY16-17  FY16-17  FY16-17  FY15-16  FY15-16  FY14-15  FY13-14  FY11-12  FY10-11  FY09-10  FY08-09  FY07-08  FY06-07  FY05-06  FY04-05 

 
Quarterly Results
 FY20-21
 FY19-20
 FY18-19
 FY17-18
 FY16-17
 FY15-16
 FY14-15
 FY13-14
 FY12-13
 FY11-12
 FY10-11
 FY09-10
 FY08-09
 FY07-08
 FY06-07
 FY05-06
 FY04-05
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2018, Biocon. All Rights Reserved